Navigation Links
ACORN Continues Success in Oncology Data Warehousing With Accumulation of Nearly 50 Million Data Observations
Date:6/16/2008

MEMPHIS, Tenn., June 16 /PRNewswire/ -- Accelerated Community Oncology Research Network(TM), an oncology-focused CRO and research network, announced today that its Oncology Data Warehouse has accumulated nearly 50 million data observations from over 110,000 oncology patients contained in its data warehouse. Integrating patient-reported outcomes (PROs), electronic medical records (EMR), claims data, and laboratory information systems, garnered from community oncology practices nationwide where 85% of cancer care is provided, the warehouse contains demographically diverse data, offering reliable information on treatments and outcomes to payers, financial institutions, pharmaceutical / biotech companies, and community oncology practices.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071112/CLM151LOGO )

"Our data warehouse is now mature enough to support longitudinal or cross- sectional analyses comparing practice patterns, toxicity, and outcomes in large groups of patients undergoing treatment for a broad range of tumor types," according to Ed Stepanski, Ph.D., Chief Operating Officer. "Additionally, several years of archived PACE System PROs provide a critical component to our Oncology Data Warehouse, allowing us to systematically analyze patients' symptom burden and quality of life, making our warehouse unique among all oncology data repositories."

Analytic data from this large-scale oncology data repository has been presented at many major oncology-related conferences and published in peer- reviewed medical journals worldwide. Furthering the field of oncology health informatics, ACORN's data warehouse has been used in numerous projects that address quality of care, patients' quality of life, overall health outcomes and the cost of care.

"Determining the most effective and least toxic treatment regimens in actual clinical practice, as opposed to a clinical trial, is a valuable end result from the data warehouse," observes Steve Coplon, CEO. "ACORN will soon double the number of unique patients in the warehouse. The warehouse runs as close to real time as is needed for projects we conduct."

ACORN will exhibit at the annual Drug Information Association meeting in Boston, June 22-25, 2008. Senior level ACORN executives will be present to discuss ACORN's Oncology Data Warehouse as well as its CRO services, Guardian EDC, and network of community oncology practices. For additional information visit http://www.ACORNresearch.net or contact Liz Conway, Director of Marketing and Corporate Services, 901-259-0878.

Accelerated Community Oncology Research Network, Inc. (ACORN)

ACORN focuses on oncology exclusively. ACORN offers centralized clinical trial services, scientific analysis, and is a full-service Clinical Research Organization (CRO), providing contract and budgeting services; fostering accrual of subjects at the site level; collecting data and monitoring its accuracy; and working seamlessly with both trial sponsors and participating practices.

Contact Information:

Liz Conway

(901) 435-5570

lconway@sosacorn.com

http://www.ACORNresearch.net

Deborah D. Coble

901-683-0055x1312

dcoble@sosacorn.com


'/>"/>
SOURCE Accelerated Community Oncology Research Network, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. ACORN Presents Findings of Collaborative Metastatic Colorectal Cancer Research
2. ACORNs Oncology-focused Contract Research Organization Exceeds Projections
3. AlphaVax Continues to Expand the Use of Its Vaccine Platform
4. Replidyne Discontinues Phase III Trial
5. Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months
6. Medarex Announces Ipilimumab Program Continues to Move Forward
7. Carpet One Floor & Home Continues Making Dramatic Strides in Funding Breast Cancer Research and Awareness
8. Nuvelo Announces Phase 2 SONOMA-3 Trial Did Not Meet Target Product Profile and Discontinues Alfimeprase Development
9. Phase I and Phase I/II DCVax(R)-Brain Data Continues to Show Significantly Improved Survival Rates for Brain Cancer Patients
10. Bone Mineral Content Continues to Increase in Obese Adolescents During Weight Loss
11. The OrthoGlide(TM) Medial Knee Implant Continues to be Accepted as an Alternative to Total Knee Replacement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... Feb. 4, 2016  SciClone Pharmaceuticals, Inc. (NASDAQ: ... has entered into a settlement agreement with the ... resolving the SEC,s investigation into possible violations of ... terms of the settlement agreement, SciClone has agreed ... disgorgement, pre-judgment interest and a penalty.  This payment ...
(Date:2/4/2016)... -- Global Immunology Market to 2022 - Large ... growth Summary Immune-mediated inflammatory diseases are ... affect 5–7% of western populations. Although they are ... key patient demographics, they are pathophysiologically linked, being ... inappropriate immune response. Generally, disease-modifying anti-rheumatic drugs, a ...
(Date:2/4/2016)...  Aethlon Medical, Inc. (Nasdaq: AEMD ), ... treat life-threatening diseases, today announced results for the ... 2015. --> --> ... our last quarterly call, we strategically advanced pre-clinical ... to establish the Aethlon Hemopurifier® as a leading ...
Breaking Medicine Technology:
(Date:2/5/2016)... York, New York (PRWEB) , ... February 05, 2016 , ... ... life? The answer may be at the tips of your toes. Foot massage, whether ... as well as pure comfort and relaxation. The American Board of Multiple Specialties ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... franchises from across the country gathered at the La Valencia Hotel in San ... PROSHRED Chicago was named the year’s most outstanding franchise, walking away with ...
(Date:2/5/2016)... ... 05, 2016 , ... Pivot Point Consulting, a leading national ... & Services for HIT Implementation Support & Staffing report with an outstanding score ... by healthcare executives, managers and clinicians representing over 4,500 hospitals and 2,500 clinics. ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... Colorize ... from on one drop zone to the next using Colorize's dynamic moving camera. Colorize ... project. This package includes a 3D slideshow environment with 1 to 5 focus points ...
(Date:2/5/2016)... ... 05, 2016 , ... Calls Blacklist has just been updated by mobile app ... the developer has fixed known bugs within the app. Calls Blacklist allows its users ... not consuming any of their device’s battery power or memory. It provides a powerful ...
Breaking Medicine News(10 mins):